IE00BDZVHG35
IE00BDZVHG35
iShares Nasdaq US Biotechnology UCITS ETF
Loading chart...
Holdings & Portfolio Structure
Holdings as of 08/30/2026Detailed breakdown of ETF components
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc. | Healthcare | Drug Manufacturers - General | 200,18 Mrd. € | 8.57% | 25.77 | 16.94 | 490.28% | 19.19 | 5.89 | 15.27 | 25.94 | 3.85% | FY Cur +5.98% (31) Q Cur +5.15% (24) FY Next +3.62% (31) Q Next +2.19% (23) | FY Cur +5.47% (33) Q Cur +2.21% (27) FY Next +6.29% (33) Q Next +0.71% (27) | |
| 2 | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 115,31 Mrd. € | 8.08% | 29.71 | 25.23 | 9.77% | 6.38 | 10.26 | 23.86 | 49.17 | 2.03% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | FY Cur -11.12% (16) Q Cur -115.38% (13) FY Next +23.62% (16) Q Next +721.48% (14) | |
| 3 | Gilead Sciences, Inc. | Healthcare | Drug Manufacturers - General | 167,29 Mrd. € | 7.32% | - | 15.24 | 223.47% | 15.86 | 6.15 | 13.95 | 19.19 | 5.21% | FY Cur +4.36% (25) Q Cur +0.17% (20) FY Next +6.57% (24) Q Next +4.63% (17) | FY Cur -105.06% (27) Q Cur -11.85% (22) FY Next +2503.59% (26) Q Next -0.10% (20) | |
| 4 | Regeneron Pharmaceuticals, Inc. | Healthcare | Biotechnology | 68,6 Mrd. € | 5.24% | 18.46 | 12.11 | 8.54% | 2.36 | 4.95 | 14.58 | 25.07 | 3.99% | FY Cur +20.31% (25) Q Cur +20.96% (19) FY Next +7.56% (23) Q Next +8.04% (18) | FY Cur +27.56% (27) Q Cur +35.49% (22) FY Next -10.42% (9) Q Next +11.61% (21) | |
| 5 | Moderna, Inc. | Healthcare | Biotechnology | 80,17 Mrd. € | 3.57% | - | -50.70 | 19.04% | 13.28 | 40.32 | -34.08 | 300.18 | 0.33% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | FY Cur -15.53% (21) Q Cur -149.18% (15) FY Next +43.00% (20) Q Next -37.19% (14) | |
| 6 | Revolution Medicines, Inc. | Healthcare | Biotechnology | 36,3 Mrd. € | 2.96% | - | -33.17 | 45.68% | 15.60 | - | -23.22 | - | -1.75% | FY Cur +0.00% (23) Q Cur +0.00% (20) FY Next +567.30% (23) Q Next +573.29% (19) | FY Cur -61.64% (23) Q Cur -48.32% (21) FY Next +40.52% (23) Q Next +17.56% (21) | |
| 7 | Illumina, Inc. | Healthcare | Diagnostics & Research | 37,49 Mrd. € | 2.17% | 51.90 | 45.46 | 89.04% | 14.80 | 9.35 | 35.77 | 52.66 | 1.90% | FY Cur +6.48% (19) Q Cur +6.34% (17) FY Next +6.46% (19) Q Next +5.84% (16) | FY Cur +10.69% (21) Q Cur +1.31% (19) FY Next +14.20% (21) Q Next +13.15% (18) | |
| 8 | Biogen Inc. | Healthcare | Drug Manufacturers - General | 29,76 Mrd. € | 2.06% | 40.09 | 13.65 | 44.33% | 1.77 | 3.33 | 11.71 | 26.32 | 3.80% | FY Cur +5.66% (32) Q Cur +4.00% (26) FY Next +2.04% (32) Q Next -1.22% (25) | FY Cur -17.96% (33) Q Cur -57.93% (26) FY Next +31.94% (33) Q Next +61.72% (26) | |
| 9 | Alnylam Pharmaceuticals, Inc. | Healthcare | Biotechnology | 27,79 Mrd. € | 1.99% | 37.83 | 18.73 | 220.62% | 22.98 | 6.48 | 28.19 | 114.66 | 0.87% | FY Cur +47.50% (26) Q Cur +14.73% (20) FY Next +26.78% (26) Q Next +9.32% (20) | FY Cur +73.90% (14) Q Cur -21.24% (14) FY Next +40.62% (14) Q Next +19.29% (14) | |
| 10 | argenx SE | Healthcare | Biotechnology | 46,31 Mrd. € | 1.84% | 31.19 | 23.76 | 0.56% | 153.25 | 9.76 | 790.35 | 68.11 | 1.47% | FY Cur +48.20% (4) Q Cur +43.13% (2) FY Next +21.64% (4) Q Next +8.94% (2) | FY Cur -4.56% (4) Q Cur -288.71% (2) FY Next +85.91% (3) Q Next +189.72% (1) | |
| 11 | Royalty Pharma plc | Healthcare | Biotechnology | 29,36 Mrd. € | 1.73% | 30.28 | 9.82 | 91.58% | 3.71 | 12.97 | 23.18 | - | -3.63% | FY Cur +7.71% (5) Q Cur +8.70% (4) FY Next +8.97% (5) Q Next +6.38% (3) | FY Cur +10.18% (6) Q Cur +0.62% (6) FY Next +8.98% (6) Q Next +28.87% (5) | |
| 12 | Roivant Sciences Ltd. | Healthcare | Biotechnology | 22,85 Mrd. € | 1.70% | - | -20.63 | 2.18% | 6.05 | 3398.72 | -15.92 | - | -4.40% | FY Cur +530.75% (12) Q Cur +136.10% (11) FY Next +685.92% (12) Q Next +231.50% (11) | FY Cur -46.66% (3) Q Cur -63.34% (3) FY Next -8.69% (3) Q Next +8.42% (3) | |
| 13 | Insmed Incorporated | Healthcare | Biotechnology | 19,61 Mrd. € | 1.66% | - | 127.76 | 97.65% | 28.99 | 19.31 | -27.07 | - | -2.60% | FY Cur +197.18% (22) Q Cur +250.76% (20) FY Next +59.72% (21) Q Next +12.87% (19) | FY Cur +75.47% (18) Q Cur +78.64% (17) FY Next +150.00% (18) Q Next +14.14% (17) | |
| 14 | Incyte Corporation | Healthcare | Biotechnology | 20,4 Mrd. € | 1.61% | 14.37 | 12.91 | 0.60% | 3.57 | 3.93 | 9.45 | 19.36 | 5.16% | FY Cur +15.49% (23) Q Cur +7.95% (20) FY Next +5.35% (23) Q Next +3.42% (19) | FY Cur -52.32% (19) Q Cur -262.56% (16) FY Next +169.37% (21) Q Next +152.33% (17) | |
| 15 | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 21,02 Mrd. € | 1.41% | 19.67 | 16.25 | - | 3.66 | 7.47 | 13.49 | 42.28 | 2.37% | FY Cur -0.74% (14) Q Cur -1.87% (13) FY Next +12.09% (14) Q Next +2.94% (13) | FY Cur -6.10% (14) Q Cur -13.24% (14) FY Next +15.44% (14) Q Next +10.83% (14) | |
| 16 | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 20,06 Mrd. € | 1.41% | - | -405.82 | - | - | 19.00 | -53.09 | 844.66 | 0.12% | FY Cur +38.24% (25) Q Cur +32.20% (21) FY Next +35.29% (25) Q Next +5.32% (20) | FY Cur +19.43% (21) Q Cur +19.79% (17) FY Next +71.86% (19) Q Next +11.31% (17) | |
| 17 | Viatris Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 18,08 Mrd. € | 1.24% | - | 6.60 | 95.53% | 1.40 | 1.37 | 7.49 | 7.57 | 13.21% | FY Cur +3.44% (9) Q Cur +1.07% (9) FY Next +1.68% (9) Q Next -2.18% (9) | FY Cur +7.07% (11) Q Cur -3.98% (10) FY Next +6.30% (11) Q Next -8.06% (10) | |
| 18 | Medpace Holdings, Inc. | Healthcare | Diagnostics & Research | 15,25 Mrd. € | 1.10% | 35.94 | 31.69 | 33.22% | 39.37 | 6.14 | 26.94 | 33.47 | 2.99% | FY Cur +12.72% (13) Q Cur +8.27% (11) FY Next +6.33% (13) Q Next +0.89% (11) | FY Cur +15.94% (10) Q Cur +15.57% (8) FY Next +9.03% (10) Q Next +5.05% (8) | |
| 19 | Jazz Pharmaceuticals plc | Healthcare | Biotechnology | 12,65 Mrd. € | 0.99% | 14.97 | 8.46 | 91.83% | 2.95 | 3.08 | 8.64 | 9.92 | 10.08% | FY Cur +10.61% (21) Q Cur +6.94% (18) FY Next +5.76% (21) Q Next +2.65% (18) | FY Cur +158.32% (19) Q Cur -61.86% (19) FY Next +19.25% (19) Q Next +109.81% (19) | |
| 20 | Neurocrine Biosciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 12,92 Mrd. € | 0.99% | 20.89 | 11.99 | 12.50% | 3.92 | 4.29 | 15.80 | 22.69 | 4.41% | FY Cur +36.44% (25) Q Cur +31.46% (23) FY Next +16.61% (24) Q Next +3.90% (22) | FY Cur +59.85% (16) Q Cur +25.70% (16) FY Next +16.28% (16) Q Next +3.92% (16) | |
| 21 | BridgeBio Pharma, Inc. | Healthcare | Biotechnology | 11,4 Mrd. € | 0.97% | - | 2261.25 | - | - | 17.92 | -32.53 | - | -2.51% | FY Cur +104.49% (19) Q Cur +124.02% (17) FY Next +65.30% (18) Q Next +17.06% (17) | FY Cur +31.71% (8) Q Cur +12.65% (7) FY Next +101.12% (7) Q Next +30.05% (7) | |
| 22 | Ascendis Pharma A/S | Healthcare | Biotechnology | 13,46 Mrd. € | 0.97% | 17.57 | 23.84 | 31.33% | 9.31 | 14.41 | 54.14 | 1181.06 | 0.08% | FY Cur +90.14% (18) Q Cur +70.76% (16) FY Next +47.13% (18) Q Next +12.98% (16) | FY Cur - (5) Q Cur - (3) FY Next -24.82% (5) Q Next +23.49% (3) | |
| 23 | Exelixis, Inc. | Healthcare | Biotechnology | 13,24 Mrd. € | 0.88% | 18.88 | 14.01 | 9.00% | 8.08 | 6.09 | 13.67 | 20.05 | 4.99% | FY Cur +10.09% (17) Q Cur +8.69% (15) FY Next +13.62% (16) Q Next +2.17% (15) | FY Cur +16.36% (10) Q Cur +14.96% (9) FY Next +19.25% (10) Q Next -0.25% (9) | |
| 24 | BioNTech SE | Healthcare | Biotechnology | 21,74 Mrd. € | 0.81% | - | -19.82 | 1.78% | 1.22 | 9.19 | -7.23 | - | -1.02% | FY Cur -37.73% (18) Q Cur -29.90% (11) FY Next +0.51% (17) Q Next -52.56% (11) | FY Cur -896.28% (10) Q Cur +730.57% (5) FY Next -2.30% (10) Q Next -199.60% (5) | |
| 25 | Halozyme Therapeutics, Inc. | Healthcare | Biotechnology | 11,19 Mrd. € | 0.80% | 32.29 | 10.39 | 1517.69% | 87.70 | 7.53 | 13.72 | 37.15 | 2.69% | FY Cur +33.93% (8) Q Cur +38.31% (6) FY Next +10.74% (8) Q Next +10.76% (6) | FY Cur +109.98% (6) Q Cur +35.12% (6) FY Next +22.02% (5) Q Next +12.69% (6) |
Results: 250
Weight 8.57%
Market Cap €200.18B
P/E 25.8
Fwd P/E 16.9
Weight 8.08%
Market Cap €115.31B
P/E 29.7
Fwd P/E 25.2
Weight 7.32%
Market Cap €167.29B
P/E -
Fwd P/E 15.2
Weight 5.24%
Market Cap €68.6B
P/E 18.5
Fwd P/E 12.1
Weight 3.57%
Market Cap €80.17B
P/E -
Fwd P/E -50.7
Weight 2.96%
Market Cap €36.3B
P/E -
Fwd P/E -33.2
Weight 2.17%
Market Cap €37.49B
P/E 51.9
Fwd P/E 45.5
Weight 2.06%
Market Cap €29.76B
P/E 40.1
Fwd P/E 13.6
Weight 1.99%
Market Cap €27.79B
P/E 37.8
Fwd P/E 18.7
Weight 1.84%
Market Cap €46.31B
P/E 31.2
Fwd P/E 23.8
Weight 1.73%
Market Cap €29.36B
P/E 30.3
Fwd P/E 9.8
Weight 1.7%
Market Cap €22.85B
P/E -
Fwd P/E -20.6
Weight 1.66%
Market Cap €19.61B
P/E -
Fwd P/E 127.8
Weight 1.61%
Market Cap €20.4B
P/E 14.4
Fwd P/E 12.9
Weight 1.41%
Market Cap €21.02B
P/E 19.7
Fwd P/E 16.3
Weight 1.41%
Market Cap €20.06B
P/E -
Fwd P/E -405.8
Weight 1.24%
Market Cap €18.08B
P/E -
Fwd P/E 6.6
Weight 1.1%
Market Cap €15.25B
P/E 35.9
Fwd P/E 31.7
Weight 0.99%
Market Cap €12.65B
P/E 15.0
Fwd P/E 8.5
Weight 0.99%
Market Cap €12.92B
P/E 20.9
Fwd P/E 12.0
Weight 0.97%
Market Cap €11.4B
P/E -
Fwd P/E 2261.2
Weight 0.97%
Market Cap €13.46B
P/E 17.6
Fwd P/E 23.8
Weight 0.88%
Market Cap €13.24B
P/E 18.9
Fwd P/E 14.0
Weight 0.81%
Market Cap €21.74B
P/E -
Fwd P/E -19.8
Weight 0.8%
Market Cap €11.19B
P/E 32.3
Fwd P/E 10.4
Results 1 - 25 of 250
Per page:
Page 1 / 10